Dr. Cartwright is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
777 Hemlock St
Macon, GA 31206Phone+1 352-804-1294
Education & Training
Emory University School of MedicineFellowship, Hematology and Medical Oncology, 1979 - 1981
Southern Illinois UniversityResidency, Internal Medicine, 1976 - 1979
Northwestern University The Feinberg School of MedicineClass of 1976
Certifications & Licensure
FL State Medical License 1981 - 2026
GA State Medical License 1979 - 2026
TN State Medical License 2024 - 2026
MD State Medical License 2022 - 2024
IL State Medical License 1977 - 1982- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma Start of enrollment: 2010 Jun 01
- A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer Start of enrollment: 2011 Jan 27
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer Start of enrollment: 2012 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 47 citationsEffects of a Brief Multimedia Psychoeducational Intervention on the Attitudes and Interest of Patients With Cancer Regarding Clinical Trial Participation: A Multicente...Paul B. Jacobsen, Kristen J. Wells, Cathy D. Meade, Gwendolyn P. Quinn, Ji-Hyun Lee
Journal of Clinical Oncology. 2012-07-10 - 377 citationsBevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trialAimery de Gramont, Eric Van Cutsem, Hans-Joachim Schmoll, Josep Tabernero, Stephen Clarke
The Lancet. Oncology. 2012-12-01 - 8226 citationsBEVACIZUMAB PLUS IRINOTECAN, FLUOROURACIL, AND LEUCOVORIN FOR METASTATIC COLORECTAL CANCERHerbert Hurwitz, Louis Fehrenbacher, William Novotny, Thomas Cartwright, John D. Hainsworth
The New England Journal of Medicine. 2004-06-03
Press Mentions
Physicians with Florida Cancer Affiliates Honored for Contributions to Clinical ResearchMarch 8th, 2016
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
